source
- Genetic Testing Helps Refine Kidney Disease Trial Design, Says Natera ExpertIn a sponsored episode of The Top Line, Dr. Ronen Schneider, Natera's medical director of renal genetics, explains how genotype‑defined kidney disease data can improve clinical trial design. He not…
- Eli Lilly halts phase 2 Alzheimer's trial of mevidalen after missing internal targetsEli Lilly announced it is removing mevidalen from its pipeline, ending a phase 2 trial in symptomatic Alzheimer's disease. The decision was disclosed during the company's third-quarter earnings up…